|
Realtime-Estimate
Andere Börsenplätze
|
% 5 Tage | Veränd. 1. Jan. | ||
| 1’805.00 GBX | -0.63% |
|
-3.84% | -1.07% |
| 16.01. | Einige Pharmakonzerne äußern sich leise besorgt über rechtliche Risiken beim beschleunigten FDA-Prüfprogramm | RE |
| 16.01. | UBS hebt Ziel für GSK auf 1940 Pence - 'Neutral' | DP |
Hauptkonkurrenten
| Dividendenrendite (Y) | Dividendenrendite (Y+1) | KGV (Y) | Price to Book (Y) | EV / Sales (Y) | Marktkap. / EBITDA (Y) | Marktkap. / EBIT (Y) | Kap.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 3.57% | 3.84% | 13.44x | 5.07x | 2.68x | 7.73x | 9.05x | 97.55 Mrd. | ||
| 0.57% | 0.64% | 45.31x | 34.64x | 15.02x | 33.36x | 36.03x | 930 Mrd. | ||
| 2.36% | 2.44% | 21.34x | 6.73x | 5.89x | 16.37x | 17.95x | 527 Mrd. | ||
| 3.05% | 3.18% | 63.59x | 678.64x | 7.14x | 17.12x | 17.64x | 379 Mrd. | ||
| 2.84% | 2.9% | 20.49x | 7.16x | 5.08x | 12.65x | 14.21x | 371 Mrd. | ||
| 1.73% | 1.82% | 28.83x | 6.5x | 5.35x | 15.87x | 16.72x | 292 Mrd. | ||
| 2.85% | 2.96% | 20x | 6.45x | 5.35x | 12.53x | 13.61x | 276 Mrd. | ||
| 2.97% | 3.02% | 13.93x | 5.01x | 4.57x | 9.84x | 11.07x | 270 Mrd. | ||
| 2.99% | 2.92% | 16.84x | 9.13x | 5.95x | 12.3x | 14.23x | 268 Mrd. | ||
| 2.89% | 3.03% | 25.84x | 19.66x | 6.13x | 10.48x | 14.06x | 178 Mrd. | ||
| 2.66% | 2.79% | 18.61x | 6.88x | 5.75x | 10.49x | 12.63x | 155 Mrd. | ||
| 6.67% | 6.85% | 12.64x | 1.61x | 3.06x | 7.66x | 8.9x | 146 Mrd. | ||
| 5.09% | 5.32% | 11.92x | 1.26x | 2.53x | 8.23x | 9.07x | 113 Mrd. | ||
| 4.46% | 4.56% | 13.47x | 5.56x | 3.03x | 8.97x | 9.37x | 112 Mrd. | ||
| -.--% | -.--% | 28.44x | 5.9x | 8.52x | 18.45x | 19.14x | 112 Mrd. | ||
| 3.08% | 1.56% | 31.69x | 6.88x | 10.19x | 19.99x | 21.36x | 85.93 Mrd. | ||
| 0.45% | 0.51% | 46.41x | 6.83x | 11.28x | 37.12x | 39.04x | 59.15 Mrd. | ||
| 3.94% | 4.01% | 42.44x | 1.17x | 2.64x | 9.85x | 27.87x | 50.71 Mrd. | ||
| -.--% | -.--% | 148.9x | 56.76x | 12.14x | 82.08x | 78.38x | 47.46 Mrd. | ||
| Durchschnitt | 2.74% | 2.75% | 32.85x | 45.88x | 6.44x | 18.48x | 20.54x | 235.28 Mrd. | |
| Gewichteter Durchschnitt nach Marktkapitalisierung | 2.39% | 2.45% | 31.02x | 70.12x | 7.62x | 18.46x | 20.24x |
- Börse
- Aktien
- A3DMB5 Aktie
- Sektor GSK plc
- branchenspezifische Dividenden
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
MarketScreener is also available in this country: United States.
Switch edition
Bei der aktuellen länderspezifischen Edition bleiben
















